HUMAN EPIDERMAL GROWTH-FACTOR - DISTINCT ROLES OF TYROSINE-37 AND ARGININE-41 IN RECEPTOR-BINDING AS DETERMINED BY SITE-DIRECTED MUTAGENESIS AND NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY

被引:65
作者
ENGLER, DA
MONTELIONE, GT
NIYOGI, SK
机构
[1] UNIV TENNESSEE,OAK RIDGE GRAD SCH BIOMED SCI,DIV BIOL,OAK RIDGE NATL LAB,POB 2009,OAK RIDGE,TN 37831
[2] UNIV TENNESSEE,OAK RIDGE GRAD SCH BIOMED SCI,PROT ENGN & MOLEC MUTAGENESIS PROGRAM,OAK RIDGE,TN 37831
[3] RUTGERS STATE UNIV,CTR ADV BIOTECHNOL & MED,PISCATAWAY,NJ 08854
[4] RUTGERS STATE UNIV,DEPT CHEM,PISCATAWAY,NJ 08854
关键词
Epidermal growth factor; Protein engineering; Rational drug design; Receptor affinity; Structure by NMR;
D O I
10.1016/0014-5793(90)80368-S
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Site-directed mutagenesis was employed to examine the function of two highly conserved residues, Tyr-37 and Arg-41, of human EGF (hEGF) in receptor binding. Both a conservative change to phenylalanine and a semi-conservative change to histidine at position 37 yield proteins with receptor affinity similar to wild-type hEGF. A non-conservative change to alanine results in a molecule with about 40% of the receptor affinity, indicating that an aromatic residue is not essential at this position. Both conservative (to lysine) and non-conservative (to alanine) substitutions at position 41 drastically reduced receptor binding to <0.5% of the wild-type activity. 1D-NMR data indicate that the replacement of Arg-41 by lysine does not significantly alter the native protein conformation. Thus, Arg-41 may be directly involved in ligand-receptor interaction, whereas the side chain of Tyr-37, although possibly important structurally, is not essential for receptor binding. © 1990.
引用
收藏
页码:47 / 50
页数:4
相关论文
共 22 条
  • [1] PURIFICATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR BY TYROSINE-SEPHAROSE AFFINITY-CHROMATOGRAPHY
    AKIYAMA, T
    KADOOKA, T
    OGAWARA, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 131 (01) : 442 - 448
  • [2] EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH FACTOR-ALPHA
    BURGESS, AW
    [J]. BRITISH MEDICAL BULLETIN, 1989, 45 (02) : 401 - 424
  • [3] CARPENTER G, 1990, J BIOL CHEM, V265, P7709
  • [4] CARPENTER G, 1985, METHOD ENZYMOL, V109, P107
  • [5] Carpenter G., 1990, HDB EXPT PHARM, P69
  • [6] THE SOLUTION STRUCTURE OF HUMAN EPIDERMAL GROWTH-FACTOR
    COOKE, RM
    WILKINSON, AJ
    BARON, M
    PASTORE, A
    TAPPIN, MJ
    CAMPBELL, ID
    GREGORY, H
    SHEARD, B
    [J]. NATURE, 1987, 327 (6120) : 339 - 341
  • [7] STRUCTURE-FUNCTION ANALYSIS OF SYNTHETIC AND RECOMBINANT DERIVATIVES OF TRANSFORMING GROWTH FACTOR-ALPHA
    DEFEOJONES, D
    TAI, JY
    WEGRZYN, RJ
    VUOCOLO, GA
    BAKER, AE
    PAYNE, LS
    GARSKY, VM
    OLIFF, A
    RIEMEN, MW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (08) : 2999 - 3007
  • [8] SUBSTITUTION OF LYSINE FOR ARGININE AT POSITION-42 OF HUMAN TRANSFORMING GROWTH FACTOR-ALPHA ELIMINATES BIOLOGICAL-ACTIVITY WITHOUT CHANGING INTERNAL DISULFIDE BONDS
    DEFEOJONES, D
    TAI, JY
    VUOCOLO, GA
    WEGRZYN, RJ
    SCHOFIELD, TL
    RIEMEN, MW
    OLIFF, A
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (09) : 4083 - 4086
  • [9] STRUCTURE-FUNCTION ANALYSIS OF EPIDERMAL GROWTH-FACTOR - SITE DIRECTED MUTAGENESIS AND NUCLEAR-MAGNETIC-RESONANCE
    DUDGEON, TJ
    COOKE, RM
    BARON, M
    CAMPBELL, ID
    EDWARDS, RM
    FALLON, A
    [J]. FEBS LETTERS, 1990, 261 (02) : 392 - 396
  • [10] ENGLER DA, 1988, J BIOL CHEM, V263, P12384